We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mutation for Hereditary Atrial Fibrillation Identified

By Biotechdaily staff writers
Posted on 24 Jan 2003
Researchers have found that a rare inherited form of atrial fibrillation (AF) is caused by a mutation in the KCNQ1 gene that encodes an ion channel subunit protein. More...
Their finding was published in the January 10, 2003, issue of Science.

Nearly one out of every 20 individuals over age 65 suffers from cardiac arrhythmia, which is increasing in prevalence as the population ages. Untreated AF can lead to heart muscle dysfunction, embolism, ventricular arrhythmia, and heart failure. Investigators studied a four-generation family in China with a history of AF. Of the 44 living members of this family from rural villages, 16 have cases of AF, all of which the researchers confirmed were hereditary. Gene mapping studies led the researchers to a region of chromosome 11 that was linked to AF. Sequence analysis revealed that there was a specific nucleotide substitution in the KCNQ1 gene in all of the family members affected with AF, but not in unaffected family members. Cell culture analyses confirmed that this genetic alteration disrupted the function of the KCNQ1 potassium channel.

The KCNQ1 potassium channel, like other ion channels, controls the electrical activity of the heart in excitable heart cells, or myocytes. "The mutation in KCNQ1 causes a marked enhancement of its function, tips the normal balance of the process, and renders the cardiac myocytes more susceptible to atrial fibrillation, explained lead authors Dr. Yi-Han Chen of Tongji University (Shanghai, China) and Dr. Shi-Jie Xu of the Chinese National Human Genome Center (Shanghai, China). "This new understanding of the molecular basis of atrial fibrillation may lead to better pre-symptomatic diagnosis of the disorder and to the development of new therapies.”


Related Links:
Tongji University
Chinese National Human Genome Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.